TRA2A and central nervous system cancer: To this end, we performed RNA-seq following TRA2A KO in a pair of glioma cell lines that we had validated to be TRA2A-dependent and independent (LN319 and LN229, respectively) (S4C–S4E Fig and S5 and S6 Tables).